MEMSCAP and OrthoMEMS team up to develop biomedical sensor
5 June 2009
MEMSCAP (Euronext:MEMS), a provider of micro-electro-mechanical
systems (MEMS), and OrthoMEMS, a medical device company focused on
biomedical applications of patented MEMS and wireless technology from
Cleveland Clinic, have entered a multi-year strategic partnership and
development agreement to manufacture a MEMS sensor for the assessment
and treatment of mechanical low back pain.
For Grenoble-based MEMSCAP, the partnership is a key component of its
plan to expand its manufacturing presence in the US medical device
sector with revolutionary products. For OrthoMEMS, the partnership
aggressively advances the development of its breakthrough spine product
all the way to market with a leading MEMS supplier to medical device
The combined experience and technologies of MEMSCAP and OrthoMEMS
enables the development and commercialization of the OrthoChip, a
miniature, battery-less, wireless pressure sensor that will provide an
objective measurement of spinal disc pressures.
The OrthoChip is designed to detect clear-cut pressure differences
between normal and mechanically unstable spinal segments and to
communicate the results telemetrically to a read-out unit. This new
capability is expected to significantly alter indications for surgery
and non-surgical treatments. No other technology, existing or emerging,
provides this advantage.
As the leading cause of adult disability, spine conditions are
widespread. An estimated 26 million people per year in the United States
alone report back pain severe enough to seek relief from a physician.
$90 Billion, or 1% of the US gross domestic product, was spent on back
pain in 1998.
“OrthoMEMS is an attractive partner because of its strong business
and scientific team and the significant commercial potential of its
spine application. This partnership is in-line with our strategic
commitment to be the lead manufacturer of MEMS in medicine,” stated
Steve Wilcenski, General Manager of the MEMSCAP Custom Products Business
“MEMSCAP has a clear track record of success in developing and
manufacturing high-value added MEMS sensors for medical use. This
strategic partnership adds real value across our full product cycle –
from the design-in phase to the market launch of our ground-breaking
product that changes the way clinicians interact with the human body,”
said Douglas Lee, Chairman and CEO of OrthoMEMS.
Bookmark this page